Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Piriou, V.
Right arrow Articles by Lehot, J. -J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Piriou, V.
Right arrow Articles by Lehot, J. -J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

British Journal of Anaesthesia, 2002, Vol. 89, No. 3 486-491
© 2002 The Board of Management and Trustees of the British Journal of Anaesthesia


research-article

Pharmacological preconditioning: comparison of desflurane, sevoflurane, isoflurane and halothane in rabbit myocardium

V. Piriou1,*, P. Chiari1, F. Lhuillier1, O. Bastien1, J. Loufoua2, O. Raisky1, J. S. David1, M. Ovize2 and J. -J. Lehot1

1 Service d'Anesthésie Réanimation Hôpital cardio-vasculaire Louis Pradel Avenue Doyen Lépine, F-69500 Lyon Bron, France
2 Laboratoire de physiologie Lyon Nord, Hôpital cardio-vasculaire Louis Pradel Avenue Doyen Lépine, F-69500 Lyon Bron, France

*Corresponding author

Background. Recent investigations showed that isoflurane can induce pharmacological preconditioning. The present study aimed to compare the potency of four different halogenated anaesthetics to induce preconditioning.

Methods. Anaesthetized open-chest rabbits underwent 30 min of coronary artery occlusion followed by 3 h of reperfusion. Before this, rabbits were randomized into one of five groups and underwent a treatment period consisting of either no intervention for 45 min (control; n = 10), or 30 min of 1 MAC halogenated anaesthetic inhalation followed by 15 min of washout. End-tidal concentrations of halogenated agents were 3.7% for sevoflurane (n = 11), 1.4% for halothane (n = 9), 2.0% for isoflurane (n = 11), and 8.9% for desflurane (n = 11). Area at risk and infarct size were assessed by blue dye injection and tetrazolium chloride staining.

Results. Mean (SD) infarct size was 54 (18)% of the risk area in untreated controls and 40 (18)% in the sevoflurane group (P>0.05, ns). In contrast, mean infarct size was significantly smaller in the halothane, isoflurane, and desflurane groups: 26 (18)%, 32 (18)% and 16 (17)%, respectively (P<0.05 vs control).

Conclusions. Halothane, isoflurane and desflurane induced pharmacological preconditioning, whereas sevoflurane had no significant effect. In this preparation, desflurane was the most effective agent at preconditioning the myocardium against ischaemia.

anaesthetics volatile heart, myocardial function


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Br J AnaesthHome page
D. T. Andrews, A. G. Royse, and C. F. Royse
Functional comparison of anaesthetic agents during myocardial ischaemia-reperfusion using pressure-volume loops
Br. J. Anaesth., November 1, 2009; 103(5): 654 - 664.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
A. Redel, J. Stumpner, T. Tischer-Zeitz, M. Lange, T. M. Smul, C. Lotz, N. Roewer, and F. Kehl
Comparison of Isoflurane-, Sevoflurane-, and Desflurane-Induced Pre- and Postconditioning Against Myocardial Infarction in Mice In Vivo
Experimental Biology and Medicine, October 1, 2009; 234(10): 1186 - 1191.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
F. Sedlic, D. Pravdic, M. Ljubkovic, J. Marinovic, A. Stadnicka, and Z. J. Bosnjak
Differences in Production of Reactive Oxygen Species and Mitochondrial Uncoupling as Events in the Preconditioning Signaling Cascade Between Desflurane and Sevoflurane
Anesth. Analg., August 1, 2009; 109(2): 405 - 411.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
H. Kitahata, J. Nozaki, S. Kawahito, T. Tomino, and S. Oshita
Low-Dose Sevoflurane Inhalation Enhances Late Cardioprotection from the Anti-Ulcer Drug Geranylgeranylacetone
Anesth. Analg., September 1, 2008; 107(3): 755 - 761.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
Y. Rao, Y.-l. Wang, W.-s. Zhang, and J. Liu
Emulsified Isoflurane Produces Cardiac Protection After Ischemia-Reperfusion Injury in Rabbits
Anesth. Analg., May 1, 2008; 106(5): 1353 - 1359.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
Y. Li, X. Zhang, B. Zhu, and Z. Xue
Desflurane Preconditioning Inhibits Endothelial Nuclear Factor-{kappa}-B Activation by Targeting the Proximal End of Tumor Necrosis Factor-{alpha} Signaling
Anesth. Analg., May 1, 2008; 106(5): 1473 - 1479.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
L. Siracusano, V. Girasole, V. Piriou, and J. Mantz
Sevoflurane and cardioprotection
Br. J. Anaesth., February 1, 2008; 100(2): 278 - 279.
[Full Text] [PDF]


Home page
Anesth. Analg.Home page
A. Redel, M. Lange, V. Jazbutyte, C. Lotz, T. M. Smul, N. Roewer, and F. Kehl
Activation of Mitochondrial Large-Conductance Calcium-Activated K+ Channels via Protein Kinase A Mediates Desflurane-Induced Preconditioning
Anesth. Analg., February 1, 2008; 106(2): 384 - 391.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
J.-L. Hanouz, L. Zhu, S. Lemoine, C. Durand, O. Lepage, M. Massetti, A. Khayat, B. Plaud, and J.-L. Gerard
Reactive Oxygen Species Mediate Sevoflurane- and Desflurane-Induced Preconditioning in Isolated Human Right Atria In Vitro
Anesth. Analg., December 1, 2007; 105(6): 1534 - 1539.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
Y. Banz, O. M. Hess, S. C. Robson, E. Csizmadia, D. Mettler, P. Meier, A. Haeberli, S. Shaw, R. A. Smith, and R. Rieben
Attenuation of myocardial reperfusion injury in pigs by Mirococept, a membrane-targeted complement inhibitor derived from human CR1
Cardiovasc Res, December 1, 2007; 76(3): 482 - 493.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
M. Zaugg
Is protection by inhalation agents volatile? Controversies in cardioprotection
Br. J. Anaesth., November 1, 2007; 99(5): 603 - 606.
[Full Text] [PDF]


Home page
Br J AnaesthHome page
S. R. Walsh, T. Tang, U. Sadat, D. P. Dutka, and M. E. Gaunt
Cardioprotection by remote ischaemic preconditioning
Br. J. Anaesth., November 1, 2007; 99(5): 611 - 616.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
V. Piriou, J. Mantz, G. Goldfarb, M. Kitakaze, P. Chiari, S. Paquin, C. Cornu, J.-B. Lecharny, P. Aussage, E. Vicaut, et al.
Sevoflurane preconditioning at 1 MAC only provides limited protection in patients undergoing coronary artery bypass surgery: a randomized bi-centre trial
Br. J. Anaesth., November 1, 2007; 99(5): 624 - 631.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
M. Meco, S. Cirri, C. Gallazzi, G. Magnani, and D. Cosseta
Desflurane preconditioning in coronary artery bypass graft surgery: a double-blinded, randomised and placebo-controlled study
Eur. J. Cardiothorac. Surg., August 1, 2007; 32(2): 319 - 325.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
X.-L. Tang, H. Sato, S. Tiwari, B. Dawn, Q. Bi, Q. Li, G. Shirk, and R. Bolli
Cardioprotection by postconditioning in conscious rats is limited to coronary occlusions <45 min
Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2308 - H2317.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
W. Y. Vanagt, R. N. Cornelussen, Q. P. Poulina, E. Blaauw, K. Vernooy, J. P. Cleutjens, M. van Bilsen, T. Delhaas, and F. W. Prinzen
Pacing-Induced Dys-Synchrony Preconditions Rabbit Myocardium Against Ischemia/Reperfusion Injury
Circulation, July 4, 2006; 114(1_suppl): I-264 - I-269.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. Lange, N. Roewer, and F. Kehl
Anesthetic preconditioning as the alternative to ischemic preconditioning
J. Thorac. Cardiovasc. Surg., January 1, 2006; 131(1): 252 - 253.
[Full Text] [PDF]


Home page
Br J AnaesthHome page
Y. Gozal, J. Raphael, J. Rivo, E. Berenshtein, M. Chevion, and B. Drenger
Isoflurane does not mimic ischaemic preconditioning in decreasing hydroxyl radical production in the rabbit
Br. J. Anaesth., October 1, 2005; 95(4): 442 - 447.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
S. G. De Hert, F. Turani, S. Mathur, and D. F. Stowe
Cardioprotection with Volatile Anesthetics: Mechanisms and Clinical Implications
Anesth. Analg., June 1, 2005; 100(6): 1584 - 1593.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
D. Obal, N. C. Weber, K. Zacharowski, O. Toma, S. Dettwiler, J. I. Wolter, M. Kratz, J. Mullenheim, B. Preckel, and W. Schlack
Role of protein kinase C-{varepsilon} (PKC{varepsilon}) in isoflurane-induced cardioprotection
Br. J. Anaesth., February 1, 2005; 94(2): 166 - 173.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
B. Haelewyn, L. Zhu, J. L. Hanouz, E. Persehaye, S. Roussel, P. Ducouret, and J. L. Gerard
Cardioprotective effects of desflurane: effect of timing and duration of administration in rat myocardium
Br. J. Anaesth., April 1, 2004; 92(4): 552 - 557.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.